
The purpose of this study was to retrospectively compare the complications associated with operatively treated ankle fractures in a group of patients with uncomplicated diabetes versus a group of patients with complicated diabetes. Outcomes of Ankle Fractures in Patients with Uncomplicated Versus Complicated Diabetesīackground: Patients with diabetes who sustain an ankle fracture are at increased risk for complications including higher rates of in hospital mortality, in-hospital postoperative complications, length of stay and non-routine discharges. Therapeutic, Retrospective comparative study, Level III. This study found no demonstrable differences between these two anticoagulants in rates of VTE, infection, reoperation, transfusion, ormajor bleeding.

.jpg)
Of the 1762 patients included, 1113 patients (63.2%) received enoxaparin and 649 patients (36.8%) received rivaroxaban. Patients who did not have unilateral primary THA/TKA or who received other anticoagulants were excluded. A retrospective cohort studywas performed including 2406 consecutive patients at our institution between 1/1/11 and 9/30/13. The purpose of our study was to compare rates of VTE and major bleeding between rivaroxaban and our previous protocol of enoxaparin after THA/TKA. The oral Factor Xa inhibitor rivaroxaban (Xarelto) has been the pharmacologic agent used for venous thromboembolism(VTE) prophylaxis after primary hip and knee arthroplasty (THA/TKA) at our institution since February 2012. Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty We evaluated demographic data, length of motor blockage, time to ambulation, time to discharge readiness, patient-reported symptoms of TNS. All patients received a single-shot spinal injection, with 2% isobaric lidocaine along with titrated propofol sedation. Methods: We performed a prospective study on 50 patients who received lidocaine spinal anesthesia in the setting of outpatient hip and knee arthroplasty. The purpose of this study is to determine the safety and efficacy of single-dose lidocaine spinal anesthesia in the setting of outpatient joint arthroplasty. However, lidocaine spinal anesthesia has been reported to have a risk of transient neurologic symptoms (TNSs). Lidocaine is a fast-onset, short-duration local anesthetic that has been used for many years in spinal anesthesia.

Single-dose lidocaine spinal anesthesia in hip and knee arthroplastyīackground: With the increasing interest in fast recovery and outpatient joint arthroplasty, short-acting local anesthetic agents and minimal narcotic use are preferred.
